# Ð¤Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»ÑŒ Ð´Ð»Ñ Pre-Revenue ÑÑ‚Ð°Ñ€Ñ‚Ð°Ð¿Ð°: Ð ÑƒÐºÐ¾Ð²Ð¾Ð´ÑÑ‚Ð²Ð¾ Ð´Ð»Ñ Healthy4U

**Ð¡Ð¸Ñ‚ÑƒÐ°Ñ†Ð¸Ñ**: Ð“Ð¾Ð´ Ñ€Ð°Ð·Ñ€Ð°Ð±Ð¾Ñ‚ÐºÐ¸ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚Ð° â†’ ÐŸÐ¸Ð»Ð¾Ñ‚ Ð² ÐºÐ»Ð¸Ð½Ð¸ÐºÐµ â†’ Ð’Ñ‹Ñ…Ð¾Ð´ Ð½Ð° Ñ€Ñ‹Ð½Ð¾Ðº â†’ Ð¤Ð°Ð½Ð´Ñ€Ð°Ð¹Ð·Ð¸Ð½Ð³
**Ð¡Ñ‚Ð°Ð´Ð¸Ñ**: Pre-revenue / Seed
**Ð”Ð°Ñ‚Ð°**: 24 ÑÐ½Ð²Ð°Ñ€Ñ 2026

---

## ðŸŽ¯ Ð’Ð°ÑˆÐ° Ñ€ÐµÐ°Ð»ÑŒÐ½Ð°Ñ ÑÐ¸Ñ‚ÑƒÐ°Ñ†Ð¸Ñ

**Ð§Ñ‚Ð¾ Ñƒ Ð²Ð°Ñ Ð•Ð¡Ð¢Ð¬**:
- âœ… Ð“Ð¾Ñ‚Ð¾Ð²Ñ‹Ð¹ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚ (Ð³Ð¾Ð´ Ñ€Ð°Ð·Ñ€Ð°Ð±Ð¾Ñ‚ÐºÐ¸)
- âœ… ÐŸÐ¸Ð»Ð¾Ñ‚Ð½Ð¾Ðµ Ð²Ð½ÐµÐ´Ñ€ÐµÐ½Ð¸Ðµ (ÐºÐ»Ð¸Ð½Ð¸ÐºÐ°)
- âœ… ÐŸÐ¾Ð½Ð¸Ð¼Ð°Ð½Ð¸Ðµ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚Ð° Ð¸ Ñ€Ñ‹Ð½ÐºÐ°
- âœ… ÐšÐ¾Ð¼Ð°Ð½Ð´Ð° Ñ ÑÐºÑÐ¿ÐµÑ€Ñ‚Ð¸Ð·Ð¾Ð¹

**Ð§ÐµÐ³Ð¾ Ñƒ Ð²Ð°Ñ ÐÐ•Ð¢**:
- âŒ ÐšÐ¾Ð¼Ð¼ÐµÑ€Ñ‡ÐµÑÐºÐ¸Ñ… Ð¿Ñ€Ð¾Ð´Ð°Ð¶
- âŒ Ð˜ÑÑ‚Ð¾Ñ€Ð¸Ð¸ revenue
- âŒ ÐŸÐ¾Ð´Ñ‚Ð²ÐµÑ€Ð¶Ð´Ñ‘Ð½Ð½Ð¾Ð³Ð¾ CAC
- âŒ Ð ÐµÐ°Ð»ÑŒÐ½Ð¾Ð³Ð¾ churn
- âŒ Validated unit economics

**Ð­Ñ‚Ð¾ ÐÐžÐ ÐœÐÐ›Ð¬ÐÐž Ð´Ð»Ñ Seed ÑÑ‚Ð°Ð´Ð¸Ð¸!** ðŸŽ‰

---

## ðŸ’¡ ÐšÐ»ÑŽÑ‡ÐµÐ²Ð¾Ð¹ Ð¿Ñ€Ð¸Ð½Ñ†Ð¸Ð¿

> **Ð˜Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ñ‹ Ð½Ð° Seed ÑÑ‚Ð°Ð´Ð¸Ð¸ ÐÐ• Ð¾Ð¶Ð¸Ð´Ð°ÑŽÑ‚ revenue!**
>
> ÐžÐ½Ð¸ Ð¸Ð½Ð²ÐµÑÑ‚Ð¸Ñ€ÑƒÑŽÑ‚ Ð²:
> 1. **Team** (ÐºÐ¾Ð¼Ð°Ð½Ð´Ð°)
> 2. **Product** (Ñ€Ð°Ð±Ð¾Ñ‚Ð°ÑŽÑ‰Ð¸Ð¹ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚)
> 3. **Market** (Ð±Ð¾Ð»ÑŒÑˆÐ¾Ð¹ Ñ€Ñ‹Ð½Ð¾Ðº)
> 4. **Traction** (Ð¿ÐµÑ€Ð²Ñ‹Ðµ ÑÐ¸Ð³Ð½Ð°Ð»Ñ‹ ÑÐ¿Ñ€Ð¾ÑÐ°)
> 5. **Vision** (Ð¿Ð»Ð°Ð½ ÐºÐ°Ðº Ð¼Ð°ÑÑˆÑ‚Ð°Ð±Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒÑÑ)

Ð¤Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»ÑŒ Ð¿Ð¾ÐºÐ°Ð·Ñ‹Ð²Ð°ÐµÑ‚ **Ð¿Ð»Ð°Ð½ Ð¿Ñ€ÐµÐ²Ñ€Ð°Ñ‰ÐµÐ½Ð¸Ñ 2-5 Ð² Ð´ÐµÐ½ÑŒÐ³Ð¸**.

---

## ðŸ“Š ÐšÐ°Ðº ÑÑ‚Ñ€Ð¾Ð¸Ñ‚ÑŒ Ñ„Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»ÑŒ Ð‘Ð•Ð— revenue history

### 1ï¸âƒ£ Ð Ð°Ð·Ð´ÐµÐ»Ð¸Ñ‚Ðµ Ð½Ð° Ð”Ð’Ð Ð¿ÐµÑ€Ð¸Ð¾Ð´Ð°

#### ÐŸÐ•Ð Ð˜ÐžÐ” 1: Ð˜ÑÑ‚Ð¾Ñ€Ð¸Ñ (Past) - 12 Ð¼ÐµÑÑÑ†ÐµÐ² Ð½Ð°Ð·Ð°Ð´ Ð´Ð¾ ÑÐµÐ³Ð¾Ð´Ð½Ñ

**Ð§Ñ‚Ð¾ Ð¿Ð¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ñ‚ÑŒ**:
- Ð Ð°Ð·Ñ€Ð°Ð±Ð¾Ñ‚ÐºÐ° Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚Ð°
- Ð Ð°ÑÑ…Ð¾Ð´Ñ‹ Ð½Ð° ÐºÐ¾Ð¼Ð°Ð½Ð´Ñƒ
- ÐŸÐ¸Ð»Ð¾Ñ‚Ð½Ð¾Ðµ Ð²Ð½ÐµÐ´Ñ€ÐµÐ½Ð¸Ðµ
- **Spending, ÐÐ• revenue**

**ÐŸÑ€Ð¸Ð¼ÐµÑ€ Ð´Ð»Ñ Healthy4U**:

| ÐœÐµÑÑÑ† | Team | Product Dev | Pilot | Total Spend | Notes |
|-------|------|-------------|-------|-------------|-------|
| Jan 2025 | $20k | $15k | - | $35k | Ð Ð°Ð·Ñ€Ð°Ð±Ð¾Ñ‚ÐºÐ° MVP |
| Feb 2025 | $20k | $15k | - | $35k | ... |
| ... | ... | ... | ... | ... | ... |
| Jul 2025 | $25k | $10k | $5k | $40k | Ð—Ð°Ð¿ÑƒÑÐº Ð¿Ð¸Ð»Ð¾Ñ‚Ð° |
| ... | ... | ... | $5k | ... | ÐŸÐ¸Ð»Ð¾Ñ‚ Ð°ÐºÑ‚Ð¸Ð²ÐµÐ½ |
| Jan 2026 | $30k | $5k | $5k | $40k | **â† Ð¡ÐµÐ¹Ñ‡Ð°Ñ Ð·Ð´ÐµÑÑŒ** |

**Ð˜Ñ‚Ð¾Ð³Ð¾ Ð·Ð° Ð³Ð¾Ð´**: ~$450k Ð¿Ð¾Ñ‚Ñ€Ð°Ñ‡ÐµÐ½Ð¾

**Ð­Ñ‚Ð¾ Ð¿Ð¾ÐºÐ°Ð·Ñ‹Ð²Ð°ÐµÑ‚**:
- âœ… Ð’Ñ‹ ÑÐµÑ€ÑŒÑ‘Ð·Ð½Ð¾ Ð²Ð»Ð¾Ð¶Ð¸Ð»Ð¸ÑÑŒ Ð² Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚
- âœ… Ð£ Ð²Ð°Ñ Ñ€ÐµÐ°Ð»ÑŒÐ½Ð°Ñ burn rate
- âœ… Ð’Ñ‹ ÑƒÐ¶Ðµ Ñ‡Ñ‚Ð¾-Ñ‚Ð¾ Ð´ÐµÐ»Ð°ÐµÑ‚Ðµ (Ð¿Ð¸Ð»Ð¾Ñ‚)

#### ÐŸÐ•Ð Ð˜ÐžÐ” 2: ÐŸÑ€Ð¾Ð³Ð½Ð¾Ð· (Future) - ÑÐ»ÐµÐ´ÑƒÑŽÑ‰Ð¸Ðµ 24-36 Ð¼ÐµÑÑÑ†ÐµÐ²

**Ð§Ñ‚Ð¾ Ð¿Ð¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ñ‚ÑŒ**:
- **Go-to-market ÑÑ‚Ñ€Ð°Ñ‚ÐµÐ³Ð¸Ñ**
- ÐŸÐµÑ€Ð²Ñ‹Ðµ Ð¿Ñ€Ð¾Ð´Ð°Ð¶Ð¸ (Ð½Ð° Ð¾ÑÐ½Ð¾Ð²Ðµ assumptions)
- ÐœÐ°ÑÑˆÑ‚Ð°Ð±Ð¸Ñ€Ð¾Ð²Ð°Ð½Ð¸Ðµ
- ÐŸÑƒÑ‚ÑŒ Ðº unit economics

**Ð­Ñ‚Ð¾ Ð¾ÑÐ½Ð¾Ð²Ð½Ð°Ñ Ñ‡Ð°ÑÑ‚ÑŒ Ð´Ð»Ñ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð¾Ð²!**

---

### 2ï¸âƒ£ Ð¤Ð¾ÐºÑƒÑ Ð½Ð° ASSUMPTIONS, Ð½Ðµ Ð½Ð° Ñ‚Ð¾Ñ‡Ð½Ð¾ÑÑ‚Ð¸

**Ð§ÐµÑÑ‚Ð½Ð¾ ÑÐºÐ°Ð¶Ð¸Ñ‚Ðµ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð°Ð¼**:

> "Ð£ Ð½Ð°Ñ Ð½ÐµÑ‚ Ð¸ÑÑ‚Ð¾Ñ€Ð¸Ð¸ Ð¿Ñ€Ð¾Ð´Ð°Ð¶, Ð¿Ð¾ÑÑ‚Ð¾Ð¼Ñƒ Ð²ÑÐµ Ñ†Ð¸Ñ„Ñ€Ñ‹ - ÑÑ‚Ð¾ Ð¾Ð±Ð¾ÑÐ½Ð¾Ð²Ð°Ð½Ð½Ñ‹Ðµ Ð¿Ñ€ÐµÐ´Ð¿Ð¾Ð»Ð¾Ð¶ÐµÐ½Ð¸Ñ Ð½Ð° Ð¾ÑÐ½Ð¾Ð²Ðµ:
> - ÐŸÐ¸Ð»Ð¾Ñ‚Ð° Ð² ÐºÐ»Ð¸Ð½Ð¸ÐºÐµ
> - Ð˜ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ Ñ€Ñ‹Ð½ÐºÐ°
> - Ð‘ÐµÐ½Ñ‡Ð¼Ð°Ñ€ÐºÐ¾Ð² Ð¸Ð½Ð´ÑƒÑÑ‚Ñ€Ð¸Ð¸
> - Ð˜Ð½Ñ‚ÐµÑ€Ð²ÑŒÑŽ Ñ Ð¿Ð¾Ñ‚ÐµÐ½Ñ†Ð¸Ð°Ð»ÑŒÐ½Ñ‹Ð¼Ð¸ ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð°Ð¼Ð¸"

**Ð¡Ð¾Ð·Ð´Ð°Ð¹Ñ‚Ðµ Ð¾Ñ‚Ð´ÐµÐ»ÑŒÐ½Ñ‹Ð¹ ÑÐ»Ð°Ð¹Ð´/Ð»Ð¸ÑÑ‚ "ASSUMPTIONS"** â¬…ï¸ Ð­Ñ‚Ð¾ ÐžÐ§Ð•ÐÐ¬ Ð²Ð°Ð¶Ð½Ð¾!

---

### 3ï¸âƒ£ ÐžÐ±Ð¾ÑÐ½ÑƒÐ¹Ñ‚Ðµ ÐºÐ°Ð¶Ð´Ñ‹Ð¹ assumption Ð´Ð°Ð½Ð½Ñ‹Ð¼Ð¸ Ð¸Ð· ÐŸÐ˜Ð›ÐžÐ¢Ð

#### ÐŸÑ€Ð¸Ð¼ÐµÑ€: Pricing ($100/Ð¼ÐµÑÑÑ†)

**âŒ ÐŸÐ»Ð¾Ñ…Ð¾**:
"ÐœÑ‹ Ñ…Ð¾Ñ‚Ð¸Ð¼ Ð±Ñ€Ð°Ñ‚ÑŒ $100/Ð¼ÐµÑÑÑ†"

**âœ… Ð¥Ð¾Ñ€Ð¾ÑˆÐ¾**:
"ÐÐ° Ð¾ÑÐ½Ð¾Ð²Ðµ Ð¿Ð¸Ð»Ð¾Ñ‚Ð° Ð² ÐºÐ»Ð¸Ð½Ð¸ÐºÐµ:
- ÐšÐ»Ð¸Ð½Ð¸ÐºÐ° Ð¿Ð»Ð°Ñ‚Ð¸Ñ‚ $0 (Ð±ÐµÑÐ¿Ð»Ð°Ñ‚Ð½Ñ‹Ð¹ Ð¿Ð¸Ð»Ð¾Ñ‚)
- ÐœÑ‹ Ð¾Ð¿Ñ€Ð¾ÑÐ¸Ð»Ð¸ 15 ÐºÐ»Ð¸Ð½Ð¸Ðº: 80% Ð³Ð¾Ñ‚Ð¾Ð²Ñ‹ Ð¿Ð»Ð°Ñ‚Ð¸Ñ‚ÑŒ $80-120
- ÐÐ½Ð°Ð»Ð¾Ð³Ð¸ Ð½Ð° Ñ€Ñ‹Ð½ÐºÐµ: $70-150/Ð¼ÐµÑÑÑ†
- ÐÐ°ÑˆÐ° Ñ†ÐµÐ½Ð½Ð¾ÑÑ‚ÑŒ Ð´Ð»Ñ ÐºÐ»Ð¸Ð½Ð¸ÐºÐ¸: ÑÐºÐ¾Ð½Ð¾Ð¼Ð¸Ñ $500/Ð¼ÐµÑÑÑ† Ð½Ð° Ð°Ð´Ð¼Ð¸Ð½Ð¸ÑÑ‚Ñ€Ð¸Ñ€Ð¾Ð²Ð°Ð½Ð¸Ð¸
- **â†’ Ð£ÑÑ‚Ð°Ð½Ð°Ð²Ð»Ð¸Ð²Ð°ÐµÐ¼ $100/Ð¼ÐµÑÑÑ† (ÐºÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ð¾)**"

#### ÐŸÑ€Ð¸Ð¼ÐµÑ€: Customer Acquisition

**âŒ ÐŸÐ»Ð¾Ñ…Ð¾**:
"ÐœÑ‹ Ð¿Ñ€Ð¸Ð²Ð»ÐµÑ‡Ñ‘Ð¼ 100 ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð¾Ð² Ð² Ð¿ÐµÑ€Ð²Ñ‹Ð¹ Ð³Ð¾Ð´"

**âœ… Ð¥Ð¾Ñ€Ð¾ÑˆÐ¾**:
"ÐÐ° Ð¾ÑÐ½Ð¾Ð²Ðµ Ð¿Ð¸Ð»Ð¾Ñ‚Ð° Ð¸ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ:
- **ÐŸÐ¸Ð»Ð¾Ñ‚**: 1 ÐºÐ»Ð¸Ð½Ð¸ÐºÐ° Ð·Ð° 2 Ð¼ÐµÑÑÑ†Ð° Ñ€Ð°Ð±Ð¾Ñ‚Ñ‹ (Ñ€ÑƒÑ‡Ð½Ñ‹Ðµ Ð¿Ñ€Ð¾Ð´Ð°Ð¶Ð¸)
- **Ð’Ð¾Ñ€Ð¾Ð½ÐºÐ°**: 50 Ñ…Ð¾Ð»Ð¾Ð´Ð½Ñ‹Ñ… Ð·Ð²Ð¾Ð½ÐºÐ¾Ð² â†’ 10 Ð²ÑÑ‚Ñ€ÐµÑ‡ â†’ 2 Ð´ÐµÐ¼Ð¾ â†’ 1 ÐºÐ»Ð¸ÐµÐ½Ñ‚
- **Conversion**: 20% Ð¾Ñ‚ Ð´ÐµÐ¼Ð¾ Ðº Ð¿Ð¾Ð´Ð¿Ð¸ÑÐºÐµ
- **Sales cycle**: 1-2 Ð¼ÐµÑÑÑ†Ð° Ð´Ð»Ñ B2B healthcare
- **ÐŸÐ»Ð°Ð½**: 1 Ð¿Ñ€Ð¾Ð´Ð°Ð²ÐµÑ† â†’ 30 Ð·Ð²Ð¾Ð½ÐºÐ¾Ð²/Ð´ÐµÐ½ÑŒ â†’ 6 Ð²ÑÑ‚Ñ€ÐµÑ‡/Ð½ÐµÐ´ÐµÐ»ÑŽ â†’ 24 Ð²ÑÑ‚Ñ€ÐµÑ‡/Ð¼ÐµÑÑÑ† â†’ 5 Ð´ÐµÐ¼Ð¾ â†’ 1-2 ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð°/Ð¼ÐµÑÑÑ†
- **â†’ ÐŸÑ€Ð¾Ð³Ð½Ð¾Ð·**: 10-15 ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð¾Ð² Ð² Ð¿ÐµÑ€Ð²Ñ‹Ðµ 6 Ð¼ÐµÑÑÑ†ÐµÐ² (1 Ð¿Ñ€Ð¾Ð´Ð°Ð²ÐµÑ†)"

#### ÐŸÑ€Ð¸Ð¼ÐµÑ€: Churn

**âŒ ÐŸÐ»Ð¾Ñ…Ð¾**:
"Churn Ð±ÑƒÐ´ÐµÑ‚ 1%"

**âœ… Ð¥Ð¾Ñ€Ð¾ÑˆÐ¾**:
"Ð£ Ð½Ð°Ñ Ð½ÐµÑ‚ Ð´Ð°Ð½Ð½Ñ‹Ñ… Ð¾ churn, Ñ‚Ð°Ðº ÐºÐ°Ðº Ð¿Ð¸Ð»Ð¾Ñ‚ Ð±ÐµÑÐ¿Ð»Ð°Ñ‚Ð½Ñ‹Ð¹ Ð¸ Ð´Ð»Ð¸Ñ‚ÑÑ 6 Ð¼ÐµÑÑÑ†ÐµÐ²:
- **ÐŸÐ¸Ð»Ð¾Ñ‚**: ÐšÐ»Ð¸Ð½Ð¸ÐºÐ° Ð°ÐºÑ‚Ð¸Ð²Ð½Ð¾ Ð¸ÑÐ¿Ð¾Ð»ÑŒÐ·ÑƒÐµÑ‚ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚ 6 Ð¼ÐµÑÑÑ†ÐµÐ², NPS = 8/10
- **Ð‘ÐµÐ½Ñ‡Ð¼Ð°Ñ€ÐºÐ¸**: B2B healthcare SaaS churn 5-10% Ð³Ð¾Ð´Ð¾Ð²Ñ‹Ñ… (0.4-0.8% Ð¼ÐµÑÑÑ‡Ð½Ñ‹Ñ…)
- **ÐÐ°ÑˆÐ° Ð·Ð°Ñ‰Ð¸Ñ‚Ð°**: Ð“Ð¾Ð´Ð¾Ð²Ñ‹Ðµ ÐºÐ¾Ð½Ñ‚Ñ€Ð°ÐºÑ‚Ñ‹ â†’ ÐµÑÑ‚ÐµÑÑ‚Ð²ÐµÐ½Ð½Ñ‹Ð¹ barri
- **â†’ Assumption**: 1% Ð¼ÐµÑÑÑ‡Ð½Ñ‹Ð¹ churn (12% Ð³Ð¾Ð´Ð¾Ð²Ð¾Ð¹) - ÐºÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ð¾ Ð´Ð»Ñ B2B Ñ ÐºÐ¾Ð½Ñ‚Ñ€Ð°ÐºÑ‚Ð°Ð¼Ð¸"

---

### 4ï¸âƒ£ Ð˜ÑÐ¿Ð¾Ð»ÑŒÐ·ÑƒÐ¹Ñ‚Ðµ Ð´Ð°Ð½Ð½Ñ‹Ðµ Ð¸Ð· ÐŸÐ˜Ð›ÐžÐ¢Ð Ð¼Ð°ÐºÑÐ¸Ð¼Ð°Ð»ÑŒÐ½Ð¾

**Ð§Ñ‚Ð¾ Ð¼Ð¾Ð¶Ð½Ð¾ Ð¸Ð·Ð²Ð»ÐµÑ‡ÑŒ Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð°**:

#### Product metrics (Ð´Ð°Ð¶Ðµ Ð±ÐµÐ· Ð¾Ð¿Ð»Ð°Ñ‚Ñ‹):
- **Engagement**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ Ñ€Ð°Ð· Ð² Ð´ÐµÐ½ÑŒ/Ð½ÐµÐ´ÐµÐ»ÑŽ Ð¸ÑÐ¿Ð¾Ð»ÑŒÐ·ÑƒÑŽÑ‚?
- **Active users**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ ÑÐ¾Ñ‚Ñ€ÑƒÐ´Ð½Ð¸ÐºÐ¾Ð² ÐºÐ»Ð¸Ð½Ð¸ÐºÐ¸ Ð¸ÑÐ¿Ð¾Ð»ÑŒÐ·ÑƒÑŽÑ‚?
- **Features usage**: ÐšÐ°ÐºÐ¸Ðµ Ñ„ÑƒÐ½ÐºÑ†Ð¸Ð¸ Ð¸ÑÐ¿Ð¾Ð»ÑŒÐ·ÑƒÑŽÑ‚ÑÑ Ð±Ð¾Ð»ÑŒÑˆÐµ Ð²ÑÐµÐ³Ð¾?
- **Session duration**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ Ð²Ñ€ÐµÐ¼ÐµÐ½Ð¸ Ð¿Ñ€Ð¾Ð²Ð¾Ð´ÑÑ‚ Ð² Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚Ðµ?
- **Retention**: ÐŸÑ€Ð¾Ð´Ð¾Ð»Ð¶Ð°ÑŽÑ‚ Ð»Ð¸ Ð¸ÑÐ¿Ð¾Ð»ÑŒÐ·Ð¾Ð²Ð°Ñ‚ÑŒ Ð¿Ð¾ÑÐ»Ðµ onboarding?

#### Qualitative feedback:
- **NPS**: Net Promoter Score (Ð¾Ð¿Ñ€Ð¾ÑÐ¸Ñ‚Ðµ!)
- **Pain points solved**: ÐšÐ°ÐºÐ¸Ðµ Ð¿Ñ€Ð¾Ð±Ð»ÐµÐ¼Ñ‹ Ñ€ÐµÑˆÐ¸Ð»Ð¸?
- **Value perceived**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ Ð¾Ð½Ð¸ Ð³Ð¾Ñ‚Ð¾Ð²Ñ‹ Ð¿Ð»Ð°Ñ‚Ð¸Ñ‚ÑŒ?
- **Decision makers**: ÐšÑ‚Ð¾ Ð¿Ñ€Ð¸Ð½Ð¸Ð¼Ð°ÐµÑ‚ Ñ€ÐµÑˆÐµÐ½Ð¸Ðµ Ð¾ Ð¿Ð¾ÐºÑƒÐ¿ÐºÐµ?
- **Buying process**: ÐšÐ°Ðº Ð¿Ñ€Ð¾Ñ…Ð¾Ð´Ð¸Ñ‚ procurement Ð² healthcare?

#### Operational learnings:
- **Onboarding time**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ Ð²Ñ€ÐµÐ¼ÐµÐ½Ð¸ Ð´Ð¾ Ð¿ÐµÑ€Ð²Ð¾Ð³Ð¾ value?
- **Support requests**: Ð¡ÐºÐ¾Ð»ÑŒÐºÐ¾ Ð¿Ð¾Ð´Ð´ÐµÑ€Ð¶ÐºÐ¸ Ð½ÑƒÐ¶Ð½Ð¾?
- **Integration complexity**: Ð›ÐµÐ³ÐºÐ¾ Ð»Ð¸ Ð¸Ð½Ñ‚ÐµÐ³Ñ€Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒ?
- **Training needed**: ÐšÐ°ÐºÐ¾Ðµ Ð¾Ð±ÑƒÑ‡ÐµÐ½Ð¸Ðµ Ñ‚Ñ€ÐµÐ±ÑƒÐµÑ‚ÑÑ?

**ÐŸÑ€ÐµÐ²Ñ€Ð°Ñ‚Ð¸Ñ‚Ðµ ÑÑ‚Ð¾ Ð² Ñ†Ð¸Ñ„Ñ€Ñ‹ Ð´Ð»Ñ Ð¼Ð¾Ð´ÐµÐ»Ð¸!**

ÐÐ°Ð¿Ñ€Ð¸Ð¼ÐµÑ€:
```
ÐŸÐ¸Ð»Ð¾Ñ‚ Ð¿Ð¾ÐºÐ°Ð·Ð°Ð»:
- 15 Ð°ÐºÑ‚Ð¸Ð²Ð½Ñ‹Ñ… Ð¿Ð¾Ð»ÑŒÐ·Ð¾Ð²Ð°Ñ‚ÐµÐ»ÐµÐ¹ Ð¸Ð· 20 Ð² ÐºÐ»Ð¸Ð½Ð¸ÐºÐµ (75% adoption)
- Average 3 sessions/day/user
- NPS = 8/10
â†’ Ð­Ñ‚Ð¾ TRACTION! ÐŸÐ¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ð¹Ñ‚Ðµ ÑÑ‚Ð¾ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð°Ð¼!
â†’ Assumption: 70% adoption rate Ð¿Ñ€Ð¸ Ð¿Ð»Ð°Ñ‚Ð½Ñ‹Ñ… Ð²Ð½ÐµÐ´Ñ€ÐµÐ½Ð¸ÑÑ…
```

---

### 5ï¸âƒ£ Ð¡Ñ‚Ñ€ÑƒÐºÑ‚ÑƒÑ€Ð° Ñ„Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»Ð¸ Ð´Ð»Ñ Seed Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð¾Ð²

#### Ð›Ð¸ÑÑ‚ 1: Executive Summary (1 ÑÑ‚Ñ€Ð°Ð½Ð¸Ñ†Ð°)

```
HEALTHY4U - EXECUTIVE SUMMARY

Stage: Seed fundraising
Ask: $XXX,XXX
Use of funds: Product (30%), Sales (40%), Team (25%), Reserve (5%)

Current State (Jan 2026):
- âœ… Product: Live in pilot clinic (6 months)
- âœ… Traction: 15 active users, NPS 8/10
- âœ… Team: 4 people (2 tech, 1 product, 1 ops)
- âœ… Spent to date: $450k (mostly development)

18-Month Plan:
- Month 3: First 3 paying customers
- Month 6: 10 customers, $10k MRR
- Month 12: 40 customers, $40k MRR
- Month 18: 100 customers, $100k MRR, approaching break-even

Key Metrics (Month 18):
- Customers: 100
- MRR: $100k â†’ ARR: $1.2M
- CAC: $150 (target based on benchmarks)
- LTV: $10,000 (assuming 1% monthly churn)
- LTV:CAC: 66x (healthy, will normalize as CAC increases with scale)
```

#### Ð›Ð¸ÑÑ‚ 2: ASSUMPTIONS (ÑÐ°Ð¼Ñ‹Ð¹ Ð²Ð°Ð¶Ð½Ñ‹Ð¹!)

**ÐšÑ€Ð¸Ñ‚Ð¸Ñ‡ÐµÑÐºÐ¸ Ð²Ð°Ð¶Ð½Ð¾ Ð´Ð»Ñ pre-revenue!**

| Category | Assumption | Source | Confidence |
|----------|-----------|---------|------------|
| **Pricing** | $100/month per clinic | Survey: 15 clinics, 80% willing to pay $80-120 | High |
| **Sales Cycle** | 45 days average | Healthcare procurement research + pilot experience | Medium |
| **Conversion Rate** | 20% demoâ†’customer | Industry benchmark for B2B SaaS | Medium |
| **Monthly Churn** | 1% | B2B healthcare benchmark (0.4-0.8%), we use 1% conservatively | Low (no data yet) |
| **CAC** | $150 target | Based on $30k marketing + $40k sales / 50 customers = $1,400, targeting $150 long-term | Low (no data yet) |
| **ARPPU Growth** | $100â†’$120â†’$150 | Planned premium features and upsell | Low |
| **Market Size** | 50,000 clinics in target regions | Market research | High |
| **Adoption Rate** | 70% of clinic staff | Pilot showed 75% adoption | Medium |
| **Sales Capacity** | 2-3 customers/month per rep | Based on 24 meetings/month Ã— 20% conversion | Medium |

**Confidence levels**:
- **High**: Ð”Ð°Ð½Ð½Ñ‹Ðµ Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð° Ð¸Ð»Ð¸ Ñ‚Ð²Ñ‘Ñ€Ð´Ñ‹Ðµ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ
- **Medium**: Ð‘ÐµÐ½Ñ‡Ð¼Ð°Ñ€ÐºÐ¸ Ð¸Ð½Ð´ÑƒÑÑ‚Ñ€Ð¸Ð¸
- **Low**: Educated guesses (Ð½Ð¾ Ð¾Ð±Ð¾ÑÐ½Ð¾Ð²Ð°Ð½Ð½Ñ‹Ðµ!)

#### Ð›Ð¸ÑÑ‚ 3: Scenarios (ÐºÐ°Ðº Ð²Ñ‹ ÑƒÐ¶Ðµ ÑÐ´ÐµÐ»Ð°Ð»Ð¸)

ÐÐ¾ Ð°Ð´Ð°Ð¿Ñ‚Ð¸Ñ€ÑƒÐ¹Ñ‚Ðµ Ð´Ð»Ñ pre-revenue:

**Base Case**: ÐšÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ñ‹Ð¹, Ð½Ð¾ Ñ€ÐµÐ°Ð»Ð¸ÑÑ‚Ð¸Ñ‡Ð½Ñ‹Ð¹
**Best Case**: Ð•ÑÐ»Ð¸ Ð²ÑÑ‘ Ð¿Ð¾Ð¹Ð´Ñ‘Ñ‚ Ñ…Ð¾Ñ€Ð¾ÑˆÐ¾
**Worst Case**: Ð”Ð»Ñ risk management

#### Ð›Ð¸ÑÑ‚ 4: Use of Funds

**ÐžÐ§Ð•ÐÐ¬ Ð²Ð°Ð¶Ð½Ð¾ Ð´Ð»Ñ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð¾Ð²!**

ÐŸÐ¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ð¹Ñ‚Ðµ Ð”Ð•Ð¢ÐÐ›Ð¬ÐÐž ÐºÑƒÐ´Ð° Ð¿Ð¾Ð¹Ð´ÑƒÑ‚ Ð´ÐµÐ½ÑŒÐ³Ð¸:

```
FUNDRAISING: $1,500,000

Product Development (30% = $450k):
â”œâ”€ Backend engineer Ã— 2        $240k (12 months)
â”œâ”€ Frontend engineer Ã— 1        $120k
â”œâ”€ Product manager Ã— 1          $60k (part-time)
â””â”€ Infrastructure & tools       $30k

Sales & Marketing (40% = $600k):
â”œâ”€ Sales rep Ã— 2                $240k (full comp with commission)
â”œâ”€ Marketing manager Ã— 1        $120k
â”œâ”€ Marketing budget             $180k
â”‚  â”œâ”€ LinkedIn ads              $60k
â”‚  â”œâ”€ Content & SEO             $40k
â”‚  â”œâ”€ Events & conferences      $40k
â”‚  â””â”€ Sales tools (CRM, etc)    $40k
â””â”€ Sales enablement             $60k

Team & Operations (25% = $375k):
â”œâ”€ CEO/Founder salary           $120k
â”œâ”€ Operations manager           $90k
â”œâ”€ Legal & accounting           $60k
â”œâ”€ Office & admin               $45k
â””â”€ HR & recruiting              $60k

Reserve (5% = $75k):
â””â”€ Buffer for unexpected

TOTAL: $1,500,000
RUNWAY: 18 months to break-even
```

#### Ð›Ð¸ÑÑ‚ 5: Milestones

**Ð§Ñ‚Ð¾ Ð¿Ð»Ð°Ð½Ð¸Ñ€ÑƒÐµÑ‚Ðµ Ð´Ð¾ÑÑ‚Ð¸Ñ‡ÑŒ Ñ ÑÑ‚Ð¸Ð¼Ð¸ Ð´ÐµÐ½ÑŒÐ³Ð°Ð¼Ð¸**:

| Milestone | Month | Description | Success Metric |
|-----------|-------|-------------|----------------|
| **First Customer** | M+1 | Close first paying customer | 1 customer, $100 MRR |
| **Product V2** | M+3 | Launch key features from roadmap | 5 new features, user feedback >7/10 |
| **10 Customers** | M+6 | Reach 10 paying customers | 10 customers, $10k MRR, <10% churn |
| **Team Scale** | M+8 | Hire 2nd sales rep + marketing manager | Team of 8 |
| **Series A Ready** | M+12 | Strong metrics for next round | 40 customers, $40k MRR, proven GTM |
| **Break-even Path** | M+18 | Close to profitability | 100 customers, $100k MRR, clear path |

---

## ðŸŽ¨ ÐšÐ°Ðº ÐŸÐ Ð•Ð—Ð•ÐÐ¢ÐžÐ’ÐÐ¢Ð¬ ÑÑ‚Ð¾ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð°Ð¼

### Pitch Deck Structure (Ð´Ð»Ñ Ñ„Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»Ð¸):

#### Slide: "Traction" (Ð½Ðµ "Revenue")

**âŒ ÐÐµ Ð³Ð¾Ð²Ð¾Ñ€Ð¸Ñ‚Ðµ**: "Ð£ Ð½Ð°Ñ Ð½ÐµÑ‚ revenue"

**âœ… Ð“Ð¾Ð²Ð¾Ñ€Ð¸Ñ‚Ðµ**:
```
TRACTION TO DATE

Pilot Deployment:
âœ“ 6 months live in production
âœ“ 15 active users (75% adoption)
âœ“ NPS: 8/10
âœ“ Key features validated

Pipeline:
âœ“ 20 qualified leads
âœ“ 5 scheduled demos next month
âœ“ 2 LOIs (letters of intent)

Learning:
âœ“ Validated pricing: $80-120/month
âœ“ Sales cycle: 45 days
âœ“ Decision makers identified
```

#### Slide: "Financial Plan"

**Ð¤Ð¾ÐºÑƒÑ Ð½Ð° ÐŸÐ ÐžÐ¡Ð¢ÐžÐ¢Ð•**:

```
18-MONTH PLAN

Fundraising: $1.5M
Runway: 18 months to break-even

Month 6:   $10k MRR  (10 customers)
Month 12:  $40k MRR  (40 customers)
Month 18: $100k MRR (100 customers)

Path to profitability clearly visible
```

**ÐžÐ´Ð¸Ð½ Ð³Ñ€Ð°Ñ„Ð¸Ðº**: MRR growth + Burn rate

#### Slide: "Unit Economics" (target)

```
TARGET UNIT ECONOMICS
(Based on industry benchmarks + pilot learnings)

ARPPU:    $100/month
CAC:      $150 (target)
LTV:      $10,000 (1% monthly churn)
LTV:CAC:  66:1 â†’ will normalize to 4:1 at scale

Payback: 1.5 months
Gross Margin: 80% (typical SaaS)

Note: These are targets, not actuals
Will track and optimize as we scale
```

**Ð§ÐµÑÑ‚Ð½Ð¾ÑÑ‚ÑŒ = Ð´Ð¾Ð²ÐµÑ€Ð¸Ðµ!**

---

## ðŸ”‘ ÐšÐ»ÑŽÑ‡ÐµÐ²Ñ‹Ðµ Ð¿Ñ€Ð¸Ð½Ñ†Ð¸Ð¿Ñ‹ Ð´Ð»Ñ Pre-Revenue Ð¼Ð¾Ð´ÐµÐ»Ð¸

### 1. Ð§ÐµÑÑ‚Ð½Ð¾ÑÑ‚ÑŒ Ð¿Ñ€ÐµÐ²Ñ‹ÑˆÐµ Ð²ÑÐµÐ³Ð¾

**Ð¡ÐºÐ°Ð¶Ð¸Ñ‚Ðµ Ð¿Ñ€ÑÐ¼Ð¾**:
- "We don't have revenue history"
- "These numbers are projections based on..."
- "Here's how we'll validate these assumptions"

Ð˜Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ñ‹ Ð—ÐÐÐ®Ð¢, Ñ‡Ñ‚Ð¾ Ð²Ñ‹ pre-revenue. ÐžÐ½Ð¸ Ð¾Ñ†ÐµÐ½Ð¸Ð²Ð°ÑŽÑ‚:
- ÐÐ°ÑÐºÐ¾Ð»ÑŒÐºÐ¾ Ð¾Ð±Ð¾ÑÐ½Ð¾Ð²Ð°Ð½Ñ‹ assumptions
- ÐŸÐ¾Ð½Ð¸Ð¼Ð°ÐµÑ‚Ðµ Ð»Ð¸ Ð²Ñ‹ ÑÐ²Ð¾Ð¹ Ñ€Ñ‹Ð½Ð¾Ðº
- ÐœÐ¾Ð¶ÐµÑ‚Ðµ Ð»Ð¸ execute

### 2. ÐšÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ñ‹Ð¹ Base Case

**Ð’Ð°Ñˆ Base Case Ð´Ð¾Ð»Ð¶ÐµÐ½ Ð±Ñ‹Ñ‚ÑŒ Ð´Ð¾ÑÑ‚Ð¸Ð¶Ð¸Ð¼Ñ‹Ð¼!**

Ð›ÑƒÑ‡ÑˆÐµ:
- ÐŸÐ¾Ð¾Ð±ÐµÑ‰Ð°Ñ‚ÑŒ 40 ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð¾Ð² Ð¸ Ð´Ð¾ÑÑ‚Ð¸Ñ‡ÑŒ 60
- Ð§ÐµÐ¼ Ð¿Ð¾Ð¾Ð±ÐµÑ‰Ð°Ñ‚ÑŒ 100 Ð¸ Ð´Ð¾ÑÑ‚Ð¸Ñ‡ÑŒ 40

**ÐŸÑ€Ð°Ð²Ð¸Ð»Ð¾**: Ð•ÑÐ»Ð¸ Ð²Ñ‹ Ð½Ð° 70% ÑƒÐ²ÐµÑ€ÐµÐ½Ñ‹ Ð² Base Case â†’ ÐžÐš

### 3. ÐŸÐ¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ð¹Ñ‚Ðµ PATH, Ð½Ðµ Ñ‚Ð¾Ñ‡ÐºÑƒ

**âŒ ÐŸÐ»Ð¾Ñ…Ð¾**: "Ð§ÐµÑ€ÐµÐ· 18 Ð¼ÐµÑÑÑ†ÐµÐ² Ð±ÑƒÐ´ÐµÑ‚ $1M ARR"

**âœ… Ð¥Ð¾Ñ€Ð¾ÑˆÐ¾**:
```
Month 0-3:   Learn & iterate (pilot â†’ first sales)
Month 3-6:   Prove sales motion (1â†’10 customers)
Month 6-12:  Scale what works (10â†’40 customers)
Month 12-18: Optimize & prepare Series A (40â†’100)
```

### 4. Ð¤Ð¾ÐºÑƒÑ Ð½Ð° LEARNING, Ð½Ðµ Ð½Ð° hitting numbers

**Ð¡ÐºÐ°Ð¶Ð¸Ñ‚Ðµ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð°Ð¼**:

"Ð­Ñ‚Ð° Ð¼Ð¾Ð´ÐµÐ»ÑŒ - hypothesis. Ð’ Ð¿ÐµÑ€Ð²Ñ‹Ðµ 6 Ð¼ÐµÑÑÑ†ÐµÐ² Ð¼Ñ‹ Ð±ÑƒÐ´ÐµÐ¼:
1. Ð¢ÐµÑÑ‚Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒ pricing ($80 vs $100 vs $120)
2. Ð˜Ð·Ð¼ÐµÑ€ÑÑ‚ÑŒ Ñ€ÐµÐ°Ð»ÑŒÐ½Ñ‹Ð¹ CAC
3. ÐžÑ‚ÑÐ»ÐµÐ¶Ð¸Ð²Ð°Ñ‚ÑŒ early churn
4. ÐžÐ¿Ñ‚Ð¸Ð¼Ð¸Ð·Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒ sales process

ÐœÑ‹ Ð±ÑƒÐ´ÐµÐ¼ update Ð¼Ð¾Ð´ÐµÐ»ÑŒ ÐµÐ¶ÐµÐ¼ÐµÑÑÑ‡Ð½Ð¾ Ð½Ð° Ð¾ÑÐ½Ð¾Ð²Ðµ learnings"

**Ð­Ñ‚Ð¾ Ð¿Ð¾ÐºÐ°Ð·Ñ‹Ð²Ð°ÐµÑ‚ Ð·Ñ€ÐµÐ»Ð¾ÑÑ‚ÑŒ!**

---

## ðŸ“‹ Ð§ÐµÐº-Ð»Ð¸ÑÑ‚ Ð´Ð»Ñ Ð²Ð°ÑˆÐµÐ¹ Ð¿Ñ€ÐµÐ·ÐµÐ½Ñ‚Ð°Ñ†Ð¸Ð¸ Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð°Ð¼

### Ð”Ð¾ Ð²ÑÑ‚Ñ€ÐµÑ‡Ð¸:

- [ ] Ð¡Ð¾Ð·Ð´Ð°Ð»Ð¸ Ð»Ð¸ÑÑ‚ "Assumptions" Ñ Ð¾Ð±Ð¾ÑÐ½Ð¾Ð²Ð°Ð½Ð¸ÑÐ¼Ð¸
- [ ] Ð—Ð°Ð¼ÐµÐ½Ð¸Ð»Ð¸ "Revenue History" Ð½Ð° "Development Timeline"
- [ ] Ð”Ð¾Ð±Ð°Ð²Ð¸Ð»Ð¸ Ð´Ð°Ð½Ð½Ñ‹Ðµ Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð° (engagement, NPS, adoption)
- [ ] ÐŸÐ¾Ð´Ð³Ð¾Ñ‚Ð¾Ð²Ð¸Ð»Ð¸ Use of Funds breakdown
- [ ] ÐžÐ¿Ñ€ÐµÐ´ÐµÐ»Ð¸Ð»Ð¸ milestones Ð½Ð° 18 Ð¼ÐµÑÑÑ†ÐµÐ²
- [ ] Ð¡Ð´ÐµÐ»Ð°Ð»Ð¸ ÐºÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ñ‹Ð¹ Base Case
- [ ] Ð§ÐµÑÑ‚Ð½Ð¾ Ð¾Ñ‚Ð¼ÐµÑ‚Ð¸Ð»Ð¸ "Low confidence" assumptions
- [ ] ÐŸÐ¾Ð´Ð³Ð¾Ñ‚Ð¾Ð²Ð¸Ð»Ð¸ Ð¾Ñ‚Ð²ÐµÑ‚Ñ‹ Ð½Ð° tough questions

### ÐÐ° Ð²ÑÑ‚Ñ€ÐµÑ‡Ðµ:

**ÐÐ°Ñ‡Ð½Ð¸Ñ‚Ðµ Ñ**:
"ÐœÑ‹ pre-revenue, Ð½Ð¾ Ñƒ Ð½Ð°Ñ ÐµÑÑ‚ÑŒ working product Ð¸ pilot traction. ÐŸÐ¾Ð·Ð²Ð¾Ð»ÑŒÑ‚Ðµ Ð¿Ð¾ÐºÐ°Ð·Ð°Ñ‚ÑŒ Ð½Ð°Ñˆ Ð¿Ð»Ð°Ð½..."

**ÐŸÐ¾Ð´Ñ‡ÐµÑ€ÐºÐ½Ð¸Ñ‚Ðµ**:
- Ð§Ñ‚Ð¾ Ð²Ñ‹ Ð—ÐÐÐ•Ð¢Ð• (Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð°)
- Ð§Ñ‚Ð¾ Ð²Ñ‹ ÐŸÐ Ð•Ð”ÐŸÐžÐ›ÐÐ“ÐÐ•Ð¢Ð• (Ñ Ð¾Ð±Ð¾ÑÐ½Ð¾Ð²Ð°Ð½Ð¸ÑÐ¼Ð¸)
- ÐšÐ°Ðº Ð²Ñ‹ Ð±ÑƒÐ´ÐµÑ‚Ðµ Ð’ÐÐ›Ð˜Ð”Ð˜Ð ÐžÐ’ÐÐ¢Ð¬ assumptions

**ÐžÐ¶Ð¸Ð´Ð°Ð¹Ñ‚Ðµ Ð²Ð¾Ð¿Ñ€Ð¾ÑÑ‹**:

**Q: "ÐŸÐ¾Ñ‡ÐµÐ¼Ñƒ Ð¸Ð¼ÐµÐ½Ð½Ð¾ $100/Ð¼ÐµÑÑÑ†?"**
A: "ÐÐ° Ð¾ÑÐ½Ð¾Ð²Ðµ Ð¾Ð¿Ñ€Ð¾ÑÐ° 15 ÐºÐ»Ð¸Ð½Ð¸Ðº, 80% Ð³Ð¾Ñ‚Ð¾Ð²Ñ‹ Ð¿Ð»Ð°Ñ‚Ð¸Ñ‚ÑŒ $80-120. ÐœÑ‹ Ð²Ñ‹Ð±Ñ€Ð°Ð»Ð¸ mid-point. Ð’ Ð¿Ð¸Ð»Ð¾Ñ‚Ðµ ÐºÐ»Ð¸Ð½Ð¸ÐºÐ° Ð²Ð¸Ð´Ð¸Ñ‚ Ñ†ÐµÐ½Ð½Ð¾ÑÑ‚ÑŒ Ð² ÑÐºÐ¾Ð½Ð¾Ð¼Ð¸Ð¸ $500/Ð¼ÐµÑÑÑ† Ð½Ð° Ð°Ð´Ð¼Ð¸Ð½Ð¸ÑÑ‚Ñ€Ð¸Ñ€Ð¾Ð²Ð°Ð½Ð¸Ð¸, Ñ‚Ð°Ðº Ñ‡Ñ‚Ð¾ $100 - ÑÑ‚Ð¾ 20% Ð¾Ñ‚ ÑÐºÐ¾Ð½Ð¾Ð¼Ð¸Ð¸, Ñ‡Ñ‚Ð¾ Ñ‚Ð¸Ð¿Ð¸Ñ‡Ð½Ð¾ Ð´Ð»Ñ B2B SaaS"

**Q: "ÐžÑ‚ÐºÑƒÐ´Ð° Ð²Ð·ÑÐ»Ð¸ 1% churn?"**
A: "Ð£ Ð½Ð°Ñ Ð¿Ð¾ÐºÐ° Ð½ÐµÑ‚ Ð´Ð°Ð½Ð½Ñ‹Ñ…, Ñ‚Ð°Ðº ÐºÐ°Ðº Ð¿Ð¸Ð»Ð¾Ñ‚ Ð±ÐµÑÐ¿Ð»Ð°Ñ‚Ð½Ñ‹Ð¹. Ð˜ÑÐ¿Ð¾Ð»ÑŒÐ·Ð¾Ð²Ð°Ð»Ð¸ B2B healthcare SaaS benchmark 0.4-0.8%, Ð¾ÐºÑ€ÑƒÐ³Ð»Ð¸Ð»Ð¸ Ð´Ð¾ 1% ÐºÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ð¾. Ð‘ÑƒÐ´ÐµÐ¼ Ð¸Ð·Ð¼ÐµÑ€ÑÑ‚ÑŒ Ñ Ð¿ÐµÑ€Ð²Ñ‹Ñ… Ð¿Ð»Ð°Ñ‚Ð½Ñ‹Ñ… ÐºÐ»Ð¸ÐµÐ½Ñ‚Ð¾Ð²"

**Q: "ÐšÐ°Ðº Ð²Ñ‹ Ð¾Ð±Ð¾ÑÐ½ÑƒÐµÑ‚Ðµ CAC $150?"**
A: "Ð­Ñ‚Ð¾ target Ð½Ð° Ð¾ÑÐ½Ð¾Ð²Ðµ LTV:CAC 4:1. Ð¡ÐµÐ¹Ñ‡Ð°Ñ CAC Ð½ÐµÐ¸Ð·Ð²ÐµÑÑ‚ÐµÐ½. Ð’ Ð¿ÐµÑ€Ð²Ñ‹Ðµ Ð¼ÐµÑÑÑ†Ñ‹ Ð¾Ð½ Ð±ÑƒÐ´ÐµÑ‚ Ð²Ñ‹ÑÐ¾ÐºÐ¸Ð¼ ($1000+), Ñ‚Ð°Ðº ÐºÐ°Ðº Ð¿Ñ€Ð¾Ð´Ð°Ð¶Ð¸ Ñ€ÑƒÑ‡Ð½Ñ‹Ðµ. ÐŸÐ»Ð°Ð½ - Ð¾Ð¿Ñ‚Ð¸Ð¼Ð¸Ð·Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒ Ð´Ð¾ $150 Ðº 12 Ð¼ÐµÑÑÑ†Ñƒ Ñ‡ÐµÑ€ÐµÐ· product-led growth ÑÐ»ÐµÐ¼ÐµÐ½Ñ‚Ñ‹ Ð¸ ÐºÐ¾Ð½Ñ‚ÐµÐ½Ñ‚-Ð¼Ð°Ñ€ÐºÐµÑ‚Ð¸Ð½Ð³"

**Q: "Ð ÐµÑÐ»Ð¸ Ð½Ðµ Ð´Ð¾ÑÑ‚Ð¸Ð³Ð½ÐµÑ‚Ðµ Ð¿Ð»Ð°Ð½Ð°?"**
A: "Ð£ Ð½Ð°Ñ 3 ÑÑ†ÐµÐ½Ð°Ñ€Ð¸Ñ. Ð”Ð°Ð¶Ðµ Ð² Worst Case Ñ 50% Ð¾Ñ‚ Ð¿Ð»Ð°Ð½Ð°, Ð¼Ñ‹ Ð´Ð¾ÑÑ‚Ð¸Ð³Ð°ÐµÐ¼ $500k ARR Ñ‡ÐµÑ€ÐµÐ· 18 Ð¼ÐµÑÑÑ†ÐµÐ², Ñ‡Ñ‚Ð¾ Ð´Ð¾ÑÑ‚Ð°Ñ‚Ð¾Ñ‡Ð½Ð¾ Ð´Ð»Ñ ÑÐ»ÐµÐ´ÑƒÑŽÑ‰ÐµÐ³Ð¾ Ñ€Ð°ÑƒÐ½Ð´Ð°. ÐŸÐ»Ð°Ð½ Ð‘: pivot pricing Ð¸Ð»Ð¸ customer segment ÐµÑÐ»Ð¸ ÑƒÐ²Ð¸Ð´Ð¸Ð¼ ÑÐ¸Ð³Ð½Ð°Ð»Ñ‹"

---

## ðŸ’¼ ÐŸÑ€Ð°ÐºÑ‚Ð¸Ñ‡ÐµÑÐºÐ¸Ð¹ ÑˆÐ°Ð±Ð»Ð¾Ð½ Ð´Ð»Ñ Ð²Ð°ÑˆÐµÐ¹ ÑÐ¸Ñ‚ÑƒÐ°Ñ†Ð¸Ð¸

### ÐžÐ±Ð½Ð¾Ð²Ð¸Ñ‚Ðµ Ð²Ð°ÑˆÑƒ Ð¼Ð¾Ð´ÐµÐ»ÑŒ ÑÐ»ÐµÐ´ÑƒÑŽÑ‰Ð¸Ð¼ Ð¾Ð±Ñ€Ð°Ð·Ð¾Ð¼:

1. **Ð›Ð¸ÑÑ‚ "Timeline"** (Ð²Ð¼ÐµÑÑ‚Ð¾ Historical Revenue)

```
HEALTHY4U JOURNEY

Q1 2025: Product Development
â”œâ”€ Built MVP
â”œâ”€ Core features completed
â””â”€ Cost: $120k

Q2 2025: Beta Testing
â”œâ”€ Internal testing
â”œâ”€ UI/UX improvements
â””â”€ Cost: $100k

Q3 2025: Pilot Launch
â”œâ”€ Deployed at clinic #1
â”œâ”€ 15 users onboarded
â””â”€ Cost: $120k

Q4 2025: Pilot Iteration
â”œâ”€ Feature improvements based on feedback
â”œâ”€ NPS: 8/10
â””â”€ Cost: $110k

Q1 2026: Go-to-Market Prep â† WE ARE HERE
â”œâ”€ Fundraising
â”œâ”€ Building sales pipeline
â””â”€ Cost: $50k (burn down existing funds)

TOTAL SPENT TO DATE: $500k
CURRENT RUNWAY: 3 months
FUNDRAISING: $1.5M for 18-month runway
```

2. **Ð›Ð¸ÑÑ‚ "Pilot Learnings"**

```
PILOT CLINIC DATA (6 months)

Product:
âœ“ 15 active users (75% of clinic staff)
âœ“ 3 sessions/day/user average
âœ“ Key features: [list top 3]
âœ“ Time saved: ~4 hours/week for clinic admin

Feedback:
âœ“ NPS: 8/10
âœ“ Main value: [specific benefit]
âœ“ Pain point solved: [specific problem]
âœ“ Willing to pay: 12/15 said yes ($80-120 range)

Operational:
âœ“ Onboarding time: 2 weeks
âœ“ Support tickets: 2-3/month (low!)
âœ“ Integration: Seamless with [existing system]
âœ“ Training needed: 1-2 hours

Decision Process:
âœ“ Decision maker: Clinic Administrator + Medical Director
âœ“ Procurement process: 1-2 months
âœ“ Approval needed from: Finance team
âœ“ Contract type: Annual preferred
```

3. **ÐžÐ±Ð½Ð¾Ð²Ð¸Ñ‚Ðµ KPI Dashboard**

Ð˜Ð·Ð¼ÐµÐ½Ð¸Ñ‚Ðµ Ð¼ÐµÑ‚Ñ€Ð¸ÐºÐ¸:

**âŒ Ð£Ð±ÐµÑ€Ð¸Ñ‚Ðµ**:
- Actual MRR (Ð½ÐµÑ‚ Ð´Ð°Ð½Ð½Ñ‹Ñ…)
- Actual Customers (Ð½Ð¾Ð»ÑŒ)

**âœ… Ð”Ð¾Ð±Ð°Ð²ÑŒÑ‚Ðµ**:
- Pipeline (leads, demos, LOIs)
- Pilot metrics (users, sessions, NPS)
- Development spend to date
- Current burn rate
- Months of runway

4. **ÐÐ´Ð°Ð¿Ñ‚Ð¸Ñ€ÑƒÐ¹Ñ‚Ðµ Scenarios**

**Base Case**: ÐÐ°Ñ‡Ð½Ð¸Ñ‚Ðµ Ñ ÐÐ£Ð›Ð¯ Ð² Month 1
```
Month 1: 0 customers, $0 MRR
Month 2-3: 1-2 customers, $100-200 MRR (from pilot conversion)
Month 4-6: 5-10 customers, $500-1,000 MRR
Month 7-12: 20-40 customers, $2k-4k MRR
Month 13-18: 50-100 customers, $5k-10k MRR
```

---

## ðŸŽ¯ Ð“Ð»Ð°Ð²Ð½Ð°Ñ Ð¼Ñ‹ÑÐ»ÑŒ

**Ð”Ð»Ñ Seed Ð¸Ð½Ð²ÐµÑÑ‚Ð¾Ñ€Ð¾Ð² Ð²Ð°ÑˆÐ° Ñ„Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»ÑŒ - ÑÑ‚Ð¾ Ð½Ðµ Ð¿Ñ€Ð¾Ð³Ð½Ð¾Ð·, Ð° ÐŸÐ›ÐÐ**

ÐžÐ½Ð¸ Ñ…Ð¾Ñ‚ÑÑ‚ Ð²Ð¸Ð´ÐµÑ‚ÑŒ:
1. âœ… Ð’Ñ‹ Ð¿Ð¾Ð½Ð¸Ð¼Ð°ÐµÑ‚Ðµ ÑÐ²Ð¾Ð¹ Ñ€Ñ‹Ð½Ð¾Ðº
2. âœ… Ð’Ð°Ñˆ Ð¿Ñ€Ð¾Ð´ÑƒÐºÑ‚ Ñ€Ð°Ð±Ð¾Ñ‚Ð°ÐµÑ‚ (Ð¿Ð¸Ð»Ð¾Ñ‚ = proof)
3. âœ… Ð’Ñ‹ Ð·Ð½Ð°ÐµÑ‚Ðµ, ÐºÐ°Ðº Ð¿Ñ€Ð¾Ð´Ð°Ð²Ð°Ñ‚ÑŒ (GTM ÑÑ‚Ñ€Ð°Ñ‚ÐµÐ³Ð¸Ñ)
4. âœ… Ð’Ñ‹ Ð¼Ð¾Ð¶ÐµÑ‚Ðµ execute (realistic milestones)
5. âœ… Ð’Ñ‹ Ñ‡ÐµÑÑ‚Ð½Ñ‹ Ð¿Ñ€Ð¾ Ñ€Ð¸ÑÐºÐ¸ (assumptions Ñ confidence levels)

**ÐÐµ ÑÑ‚ÐµÑÐ½ÑÐ¹Ñ‚ÐµÑÑŒ Ð¾Ñ‚ÑÑƒÑ‚ÑÑ‚Ð²Ð¸Ñ revenue - ÑÑ‚Ð¾ Ð½Ð¾Ñ€Ð¼Ð°Ð»ÑŒÐ½Ð¾ Ð½Ð° Ð²Ð°ÑˆÐµÐ¹ ÑÑ‚Ð°Ð´Ð¸Ð¸!**

Ð¤Ð¾ÐºÑƒÑÐ¸Ñ€ÑƒÐ¹Ñ‚ÐµÑÑŒ Ð½Ð° traction Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð° Ð¸ Ñ‡Ñ‘Ñ‚ÐºÐ¾Ð¼ Ð¿Ð»Ð°Ð½Ðµ Ð¼Ð¾Ð½ÐµÑ‚Ð¸Ð·Ð°Ñ†Ð¸Ð¸.

---

## ðŸ“ž Ð¡Ð»ÐµÐ´ÑƒÑŽÑ‰Ð¸Ðµ ÑˆÐ°Ð³Ð¸ Ð´Ð»Ñ Ð²Ð°Ñ

1. **Ð¡Ð¾Ð±ÐµÑ€Ð¸Ñ‚Ðµ Ð’Ð¡Ð• Ð´Ð°Ð½Ð½Ñ‹Ðµ Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð°**
   - Metrics, feedback, surveys
   - ÐŸÑ€ÐµÐ²Ñ€Ð°Ñ‚Ð¸Ñ‚Ðµ Ð² assumptions

2. **Ð¡Ð¾Ð·Ð´Ð°Ð¹Ñ‚Ðµ Ð¾Ñ‚Ð´ÐµÐ»ÑŒÐ½Ñ‹Ð¹ deck "Pilot Results"**
   - 3-5 ÑÐ»Ð°Ð¹Ð´Ð¾Ð²
   - ÐšÐ¾Ð½ÐºÑ€ÐµÑ‚Ð½Ñ‹Ðµ Ñ†Ð¸Ñ„Ñ€Ñ‹ Ð¸ quotes

3. **ÐžÐ±Ð½Ð¾Ð²Ð¸Ñ‚Ðµ Ñ„Ð¸Ð½Ð¼Ð¾Ð´ÐµÐ»ÑŒ**
   - Timeline Ð²Ð¼ÐµÑÑ‚Ð¾ history
   - Assumptions Ð»Ð¸ÑÑ‚ (ÑÐ°Ð¼Ð¾Ðµ Ð²Ð°Ð¶Ð½Ð¾Ðµ!)
   - ÐšÐ¾Ð½ÑÐµÑ€Ð²Ð°Ñ‚Ð¸Ð²Ð½Ñ‹Ð¹ Base Case

4. **ÐŸÐ¾Ð´Ð³Ð¾Ñ‚Ð¾Ð²ÑŒÑ‚Ðµ FAQ**
   - "ÐŸÐ¾Ñ‡ÐµÐ¼Ñƒ ÑÑ‚Ð¾Ñ‚ churn?"
   - "ÐžÑ‚ÐºÑƒÐ´Ð° ÑÑ‚Ð¾Ñ‚ CAC?"
   - "ÐšÐ°Ðº Ð²Ð°Ð»Ð¸Ð´Ð¸Ñ€ÑƒÐµÑ‚Ðµ assumptions?"

5. **ÐŸÑ€Ð°ÐºÑ‚Ð¸ÐºÑƒÐ¹Ñ‚Ðµ Ð¿Ð¸Ñ‚Ñ‡**
   - "We're pre-revenue BUT..."
   - ÐŸÐ¾ÐºÐ°Ð·Ñ‹Ð²Ð°Ð¹Ñ‚Ðµ traction Ð¸Ð· Ð¿Ð¸Ð»Ð¾Ñ‚Ð°
   - Ð§ÐµÑÑ‚Ð½Ð¾ÑÑ‚ÑŒ Ð¿Ñ€Ð¾ assumptions

**Ð£Ð´Ð°Ñ‡Ð¸ Ñ Ñ„Ð°Ð½Ð´Ñ€Ð°Ð¹Ð·Ð¸Ð½Ð³Ð¾Ð¼!** ðŸš€

P.S. Ð¥Ð¾Ñ‚Ð¸Ñ‚Ðµ, Ð¿Ð¾Ð¼Ð¾Ð³Ñƒ Ð°Ð´Ð°Ð¿Ñ‚Ð¸Ñ€Ð¾Ð²Ð°Ñ‚ÑŒ ÐºÐ¾Ð½ÐºÑ€ÐµÑ‚Ð½Ñ‹Ðµ Ð»Ð¸ÑÑ‚Ñ‹ Ð²Ð°ÑˆÐµÐ¹ Ð¼Ð¾Ð´ÐµÐ»Ð¸ Ð¿Ð¾Ð´ pre-revenue Ñ„Ð¾Ñ€Ð¼Ð°Ñ‚?
